Celastrol has been shown to inhibit angiogenesis, migration, and invasion and to suppress cancer progression, by affecting multiple targets in cancer cells, including the IKK-NF-κB pathway, HSP90, and the proteasome (Chen et al. 2018). Here, HSP90AA1 is linked to cancer.